Gqg Partners LLC Astrazeneca PLC Transaction History
Gqg Partners LLC
- $62.5 Billion
- Q1 2025
A detailed history of Gqg Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gqg Partners LLC holds 1,457,030 shares of AZN stock, worth $103 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,457,030
Previous 4,375,340
66.7%
Holding current value
$103 Million
Previous $287 Million
62.64%
% of portfolio
0.17%
Previous 0.43%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
505MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.04 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.88 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.52 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.22 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...